ResearcherCapital Medical UniversityActive in the last 2 years

Zhuoyin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2458-7873; OpenAlex author ID A5086240595. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 2 papers

Papers 2

PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. Co-author DOI 10.1016/j.lfs.2025.124060 ↗
Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer. Co-author DOI 10.1111/cas.16418 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bin Zhu · 2 shared papers, 2025 · strength 0.54
- Paper PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. DOI 10.1016/j.lfs.2025.124060 ↗
- Paper Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer. DOI 10.1111/cas.16418 ↗
Nengwei Zhang · 2 shared papers, 2025 · strength 0.54
- Paper PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. DOI 10.1016/j.lfs.2025.124060 ↗
- Paper Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer. DOI 10.1111/cas.16418 ↗
Xu Guo · 1 shared paper, 2025 · strength 0.27
- Paper PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. DOI 10.1016/j.lfs.2025.124060 ↗
Jing Wang · 1 shared paper, 2025 · strength 0.27
- Paper PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. DOI 10.1016/j.lfs.2025.124060 ↗
Jili Hu · 1 shared paper, 2025 · strength 0.27
- Paper PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. DOI 10.1016/j.lfs.2025.124060 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.